Sleep apnea hypopnea syndrome and liver injury

Chinese Medical Journal

Volumn 123, Issue 1, 2010, Pages 89-94

  Tian, Jian Li ^a   Zhang, Yun ^a   Chen, Bao Yuan ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Insulin resistance; Intermittent hypoxia; Nonalcoholic fatty liver disease; Oxidative stress; Sleep apnea hypopnea syndrome

Indexed keywords

AMINOTRANSFERASE;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; FATTY LIVER; FEMALE; HEPATITIS; HUMAN; INSULIN RESISTANCE; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER INJURY; LIVER NECROSIS; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; REVIEW; SLEEP APNEA SYNDROME;

ANIMALS; ANOXIA; FATTY LIVER; HUMANS; INSULIN RESISTANCE; LIVER DISEASES; OXIDATIVE STRESS; SLEEP APNEA SYNDROMES;

EID: 74749096686     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.01.016     Document Type: Review

References (44)

1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-1235.
2. Strollo PJ, Rogers RM. Obstructive sleep apnea. N Engl J Med 1996; 334: 99-104.
3. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002; 165: 677-682.
4. Arias MA, Alonso-Fernandez A, Garcia-Rio F, Pagola C. Association between obesity and obstructive sleep apnea. Eur Heart J 2005; 26: 2744-2745.
5. Cen BY. To improve the knowledge of the mechanisms of systemic damage in sleep apnea intermittent hypoxia model. Chin J Tuberc Respir Dis (Chin) 2008; 31: 641-643.
6. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001; 163: 19-25.
7. Lavie L. Sleep apnea syndrome, endothelial dysfunction, and cardiovascular morbidity. Sleep 2004; 27: 1053-1055.
8. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005; 353: 2034-2041.
9. McNicholas WT, Bonsignore MR, Management Committee of EUCOST ACTION B26. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007; 29: 156-178.
10. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apneahypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046-1053.
11. Tanne F, Gagnadoux F, Chazouilleres O, Fleury B, Wendum D, Lasnier E. Chronic liver injury during obstructive sleep apnea. Hepatology 2005; 41: 1290-1296.
12. Savransky V, Nanayakkara A, Vivero A, Li J, Bevans S, Smith PL, et al. Chronic intermittent hypoxia predisposes to liver injury. Hepatology 2007; 45: 1007-1013.
13. Kallwitz ER, Herdegen J, Madura J, Jakate S, Cotler SJ. Liver enzymes and histology in obese patients with obstructive sleep apnea. J Clin Gastroenterol 2007; 41: 918-921.
14. Mishra P, Nugent C, Afendy A, Bai C, Bhatia P, Afendy M, et al. Apnoeic-hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis. Liver Int 2008; 28: 1080-1086.
15. Norman D, Bardwell WA, Arosemena F, Nelesen R, Mills PJ, Loredo JS, et al. Serum aminotransferase levels are associated with markers of hypoxia in patients with obstructive sleep apnea. Sleep 2008; 31: 121-126.
16. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 2003; 37: 1202-1219.
17. Sass DA, Chang P, Chopra KB. Nonalcoholic fatty liver disease: a clinical review. Dig Dis Sci 2005; 50: 171-180.
18. Meigs JB, Wilson PW, Nathan DM, D'Agostino RB Sr, Williams K, Haffner SM. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003; 52: 2160-2167.
19. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002; 165: 670-676.
20. Bonora E, Kiechl S, Wileit J, Oberhollenzer F, Egger G, Targher G, et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck study. Diabetes 1998; 47: 1643-1649.
21. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917-923.
22. Vgontzas AN, Bixler EO, Chrousos GP. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 2005; 9: 211-224.
23. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-1384.
24. Li J, Savransky V, Nanayakkara A, Smith PL, O'Donnell CP, Polotsky VY. Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. J Appl Physiol 2007; 102: 557-563.
25. Li J, Grigoryev DN, Ye SQ, Thorne L, Schwartz AR, Smith PL, et al. Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice. J Appl Physiol 2005; 99: 1643-1648.
26. Chin K, Nakamura T, Takahashi K, Sumi K, Ogawa Y, Masuzaki H, et al. Effects of obstructive sleep apnea syndrome on serum aminotransferase levels in obese patients. Am J Med 2003; 114: 370-376.
27. Jouet P, Sabate JM, Maillard D, Msika S, Mechler C, Ledoux S, et al. Relationship between obstructive sleep apnea and liver abnormalities in morbidly obese patients: a prospective study. Obes Surg 2007; 17: 478-485.
28. Tatsumi K, Saibara T. Effects of obstructive sleep apnea syndrome on hepatic steatosis and nonalcoholic steatohepatitis. Hepatol Res 2005; 33: 100-104.
29. Savransky V, Bevans S, Nanayakkara A, Li J, Smith PL, Torbenson MS, et al. Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol 2007; 293: G871-G877.
30. Polotsky VY, Patil SP, Savransky V, Laffan A, Fonti S, Frame LA, et al. Obstructive sleep apnea, insulin resistance and steatohepatitis in severe obesity. Am J Respir Crit Care Med 2009; 179: 228-234.
31. Henrion J, Colin L, Schapira M, Heller FR. Hypoxic hepatitis caused by severe hypoxemia from obstructive sleep apnea. J Clin Gastroenterol 1997; 24: 245-249.
32. Mathurin P, Durand F, Ganne N, Mollo JL, Lebrec D, Degott C, et al. Ischemic hepatitis due to obstructive sleep apnea. Gastroenterology 1995; 109: 1682-1684.
33. Henrion J, Schapira M, Luwaert R, Colin L, Delannoy A, Heller FR. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine 2003; 82: 392-406.
34. American Diabetes Association. Consensus development conference on insulin resistance. Diabetes Care 1998; 21: 310-314.
35. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 2004; 114: 147-152.
36. Solis Herruzo JA, Garcia Ruiz I, Perez Carreras M, Munoz Yague MT. Non-alcoholic fatty liver disease. From insulin resistance to mitochondrial dysfunction. Rev Esp Enferm Dig 2006; 98: 844-874.
37. Zhang XL. Obstructive sleep apnea syndrome and insulin resistance. Chin J Tuberc Respir Dis (Chin) 2008; 31: 644-646.
38. Carneiro G, Ribeiro Filho FF, Togeiro SM, Tufik S, Zanella MT. Interactions between obstructive sleep apnea syndrome and insulin resistance. Arq Bras Endocrinol Metabol 2007; 51: 1035-1040.
39. Lavie L. Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med Rev 2003; 7: 35-51.
40. Lavie L, Vishnevsky A, Lavie P. Evidence for lipid peroxidation in obstructive apnea. Sleep 2004; 27: 123-128.
41. Suzuki YJ, Jain V, Park AM, Day RM. Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radic Biol Med 2006; 40: 1683-1692.
42. Yamauchi M, Kimura H. Oxidative stress in obstructive sleep apnea: putative pathways to the cardiovascular complications. Antioxid Redom Signal 2008; 10: 755-768.
43. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998; 114: 842-845.
44. Day CP, Saksena S. Non-alcoholic steatohepatitis: definitions and pathogenesis. J Gastroenterol Hepatol 2002; 17 Suppl 3: S377-S384.